Sobi updates outlook for 2016
February 29, 2016 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) is updating its outlook for 2016. Following the positive opinion for Alprolix® received from the Committee for Medicinal Products for Human Use (CHMP)...
Sobi och Biogen får CHMP-rekommendation för Alprolix® (rFIXFc) för behandling av hemofili B
February 26, 2016 07:14 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) (STO: SOBI) och Biogen (NASDAQ: BIIB) har erhållit en rekommendation om marknadsgodkännande för Alprolix® (rFIXFc) från den vetenskapliga kommittén för...
Sobi and Biogen receive positive opinion from CHMP for Alprolix® (rFIXFc) for the treatment of haemophilia B
February 26, 2016 07:14 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) (STO: SOBI) and Biogen (NASDAQ: BIIB) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European...
Bo Jesper Hansen to step down as Chairman of Sobi - Håkan Björklund to be nominated as new Chairman of the Board
February 26, 2016 02:02 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB's (publ) (Sobi(TM)) Chairman of the Board, Bo Jesper Hansen, MD, PhD, has informed the Sobi's nomination committee that he will not stand for re-election at the 2016...
Bo Jesper Hansen avgår som styrelseordförande i Sobi - Håkan Björklund att nomineras till ny ordförande
February 26, 2016 02:02 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB:s (publ) (Sobi(TM)) styrelseordförande, MD, PhD, Bo Jesper Hansen har meddelat Sobis valberedning att han inte kommer att ställa upp för omval vid årsstämman 2016. Bo...
Sobi publicerar sin rapport för fjärde kvartalet samt helåret 2015
February 26, 2016 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) presenterade idag sin bokslutskommuniké för 2015. Intäkterna för helåret uppgick till total 3 228 MSEK (2 607), en ökning med 24 procent jämfört 2014....
Sobi publishes its report for the fourth quarter and full year 2015
February 26, 2016 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) today announced its results for the fourth quarter and full year 2015. Revenues for the full year totalled SEK 3,228 M (2,607), an increase of 24 per...
Chief Medical Officer Birgitte Volck lämnar Sobi
January 14, 2016 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) medddelade idag att Birgitte Volck, M.D., Ph.D., Senior Vice President Development och Chief Medical Officer (CMO) kommer att lämna Sobi för att ansluta...
Chief Medical Officer Birgitte Volck to leave Sobi
January 14, 2016 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that Birgitte Volck, M.D., Ph.D., Senior Vice President of Development and Chief Medical Officer (CMO) of Sobi, will leave the company to...
Lars Dreiøe joins Sobi as Senior Vice President, Chief Quality & Compliance Officer
December 21, 2015 02:00 ET
|
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that Lars Dreiøe has been appointed Senior Vice President Chief Quality & Compliance Officer (CQCO). Lars Dreiøe joins Sobi from global...